EGFR and cancer: Overexpression or hyperactivation of the EGFR is associated with poor prognosis in many human cancers, including metastatic colorectal cancer (mCRC), head and neck squamous cell carcinoma (HNSCC), non-small cell lung cancer (NSCLC) and brain cancer [3–6].